Glutathione-related factors are not correlated with sensitivity of human tumour cells to actinomycin D

Cancer Letters

Volumn 149, Issue 1-2, 2000, Pages 213-220

  Zhang, Kai ^a   Yang, Er Bin ^a   Zhao, Yin Nong ^a   Wong, Kim Ping ^b   Mack, Peter ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Actinomycin D; Glutathione; Glutathione conjugate export pump; Glutathione peroxidase; Glutathione reductase; Glutathione S transferase; Human tumour cells; Melphalan

Indexed keywords

DACTINOMYCIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; MELPHALAN;

ARTICLE; CONTROLLED STUDY; DRUG DETOXIFICATION; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME ASSAY; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; TUMOR CELL;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; DACTINOMYCIN; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE; HUMANS; MELPHALAN; NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0342879907     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00364-X     Document Type: Article

References (29)

1. Commandeur J.N.M., Stijntjes G.J., Vermeulen N.P.E. Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Pharmacol. Rev. 47:1995;271-330.
2. Zhang K., Mack P., Wong K.P. Glutathione-related mechanisms in cellular resistance to anticancer drugs. Int. J. Oncol. 12:1998;871-882.
3. Dulik D.H., Fenselau C., Hilton J. Characterisation of melphalan-glutathione adducts whose formation is catalysed by glutathione transferases. Biochem. Pharmacol. 35:1986;3404-3409.
4. Hall A.G., Matheson E., Hickson I.D., Foster S.A., Hogarth L. Purification of an alpha class glutathione S-transferase from melphalan-resistant Chinese hamster ovary cells and demonstration of its ability to catalyse melphalan-glutathione adduct formation. Cancer Res. 54:1994;3369-3372.
5. Barnouin K., Leier I., Jedlitschky G., Pourtier-Manzanedo A., Konig J., Lehmann W.D., Keppler D. Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione. Br. J. Cancer. 77:1998;201-209.
6. Tew K.D., Bomber A.M., Hoffman S.J. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res. 48:1988;3622-3625.
7. Hasson J., Berhane K., Gastro V.M., Junhelius U., Mannervik B., Ringberg U. Sensitization of human melanoma cells to cytotoxic effects of melphalan by glutathione transferase inhibitor ethacrynic acid. Cancer Res. 51:1991;94-98.
8. Caffrey P.B., Zhu M., Zhang Y., Chinen N., Frenkel G.D. Rapid development of glutathione S-transferase-dependent drug resistance in vitro and its prevention by ethacrynic acid. Cancer Lett. 136:1999;47-52.
9. Anderson C.P., Tsai J., Chan W., Park C.K., Tian L., Lui R.M., Forman H.J., Reynolds C.P. Buthionine sulphoximine alone and in combination with melphalan is highly cytotoxic for human neuroblastoma cell lines. Eur. J. Cancer. 33:1997;2016-2019.
10. Chabner B.A., Allegra C.J., Curt G.A., Colabres P. Antineoplastic agents. Hardman J.G., Limbird L.E. The Pharmacological Basis of Therapeutics. 1996;1233-1287 Goodman & Gilman, New York.
11. Ferrari S., Mercuri M., Rosito P., Mancini A., Barbieri E., Longhi A., Rimondini S., Cesari M., Ruggieri P., Di Liddo M., Bacci G. Ifosfamide and actinomycin D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve in patients with non-metastatic Ewing's sarcoma. J. Chemother. 10:1998;484-491.
12. 3H-actinomycin D in the rat, monkey and dog. Cancer Chemother. Rep. 59:1975;1061-1069.
13. Tew K.D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54:1994;4313-4320.
14. Salinas A.E., Wong M.G. Glutathione S-transferase - a review. Curr. Med. Chem. 6:1999;279-309.
15. Hanson M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Med. 119:1989;203-210.
16. Zhang K., Wong K.P. Inhibition of the efflux of glutathione S-conjugate by plant polyphenols. Biochem. Pharmacol. 52:1996;1631-1638.
17. Habig W.H., Pabst M.T., Jacoby W.B. Glutathione S-transferases: the first enzyme step in mercapturic acid formation. J. Biol. Chem. 249:1974;7130-7139.
18. Zhang K., Yang E.B., Tang W.Y., Wong K.P., Mack P. Inhibition of glutathione reductase by plant polyphenols. Biochem. Pharmacol. 54:1997;1047-1053.
19. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70:1967;158-169.
20. Oude Elferink R.P.J., Bakker C.T.M., Jansen P.L.M. Glutathione conjugate transport by human colon adenocarcinoma cells. Biochem. J. 290:1993;759-764.
21. Zhang K., Das N.P. Inhibitory effects of plant polyphenols on rat liver glutathione S-transferases. Biochem. Pharmacol. 47:1994;2063-2068.
22. Bradford M.M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
23. Zhang K., Yang E.B., Wong K.P., Mack P. GSH, GSH-related enzymes and GS-X pump in relation to sensitivity of human tumour cell lines to chlorambucil and Adriamycin. Int. J. Oncol. 14:1999;861-867.
24. Lunel-Orsini C., Buttin G., De Saint Vincent B.R. A glutathione depletion selectively imposed on mu glutathione S-transferase overproducing cells increases nitrogen mustard toxicity. Biochem. Pharmacol. 31:1995;363-370.
25. Zhang K., Wong K.P. Glutathione conjugation of chlorambucil: measurement and modulation by plant polyphenols. Biochem. J. 325:1997;417-422.
26. Samuels B.L., Murray J.L., Cohen M.B., Safa A.R., Sinha B.K., Townsend A.J., Beckett M.A., Weichselbaum R.R. Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance. Cancer Res. 51:1991;521-527.
27. Chen X., Batist G. Sensitization effect of L-2-oxothiazolidine-4-carboxylate on tumor cells to melphalan and the role of 5-oxo-L-prolinase in glutathione modulation in tumor cells. Biochem. Pharmacol. 56:1998;743-749.
28. Gafferey P.B., Zhu M., Frenkel G.D. Prevention of the development of melphalan resistance in vitro by selenite. Bio. Trace Elem. Res. 65:1998;187-195.
29. Morgan A.S., Ciaccio P.J., Tew K.D., Kauvar L.M. Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother. Pharmacol. 37:1996;363-370.